Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.transgenebiotek.com | |
Market Cap | 30.08 Cr. | |
Enterprise Value(EV) | 42.61 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -0.93 | Trailing Twelve Months Ending 2022-12 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-12 |
Industry PE | 49.39 | Trailing Twelve Months Ending 2022-12 |
Book Value / Share | 1.69 | Trailing Twelve Months Ending 2022-12 |
Price to Book Value | 2.34 | Calculated using Price: 3.97 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 7.58 Cr. | 75,770,000 Shares |
FaceValue | 10 | |
About Transgene Biotek Ltd. | ||
Transgene Biotek Ltd (TBL) was set up in 1991, and was probably the first true Biotechnology Company in India. It is listed on the Indian Stock Exchanges and is involved in the development of several cutting edge technologies. |
1 Day |
|
-0.75% |
1 Week |
|
+1.28% |
1 Month |
|
+60.73% |
3 Month |
|
+58.80% |
6 Month |
|
+38.81% |
1 Year |
|
+13.75% |
2 Year |
|
-4.57% |
5 Year |
|
+81.28% |
10 Year |
|
+118.13% |
9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | -50.54 | -9.63 | -11.78 | -17.03 | -11.57 | -18.31 | -28.73 | -38.00 | -52.52 | |
Return on Capital Employed (%) | -47.36 | -8.84 | -10.85 | -14.68 | -6.74 | -14.83 | -22.10 | -26.55 | -32.32 | |
Return on Assets (%) | -36.70 | -5.45 | -6.56 | -7.77 | -3.35 | -4.84 | -6.39 | -6.45 | -6.84 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 206 | 191 | 174 | 59 | 52 | 44 | 33 | 22 | 17 | 14 | |
Non Curr. Liab. | 127 | 127 | 127 | 127 | 120 | 120 | 120 | 120 | 121 | 121 | |
Curr. Liab. | 26 | 25 | 11 | 12 | 14 | 13 | 14 | 14 | 9 | 10 | |
Minority Int. | |||||||||||
Equity & Liab. | 358 | 344 | 313 | 198 | 187 | 177 | 167 | 157 | 147 | 145 | |
Non Curr. Assets | 338 | 326 | 310 | 197 | 186 | 176 | 166 | 156 | 146 | 144 | |
Curr. Assets | 20 | 18 | 3 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | |
Misc. Exp. not W/O | |||||||||||
Total Assets | 358 | 344 | 313 | 198 | 187 | 177 | 167 | 157 | 147 | 145 |
Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-12 Rs. Cr. TTM |
Net Sales | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
Other Income | 1 | 0 | 0 | 1 | 7 | 2 | 0 | 0 | 0 | 0 | |
Total Income | 2 | 0 | 0 | 1 | 7 | 2 | 0 | 0 | 0 | 0 | |
Total Expenditure | -3 | -2 | -1 | -3 | -2 | -1 | -1 | -1 | -1 | -1 | |
PBIDT | -1 | -2 | -1 | -2 | 5 | 1 | -1 | 0 | 0 | -1 | |
Interest | 0 | 0 | 0 | -1 | 0 | 0 | 0 | 0 | 0 | ||
Depreciation | -17 | -17 | -21 | -18 | -10 | -10 | -10 | -10 | -10 | -6 | |
Taxation | -1 | ||||||||||
Exceptional Items | -115 | ||||||||||
PAT | -133 | -19 | -22 | -20 | -6 | -9 | -11 | -10 | -10 | -7 | |
Minority Interest | |||||||||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | -133 | -19 | -22 | -20 | -6 | -9 | -11 | -10 | -10 | -7 | |
Adjusted EPS | -18 | -3 | -3 | -3 | -1 | -1 | -1 | -1 | -1 | -1 |
Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 13 | -2 | 4 | 6 | 0 | -1 | -2 | 0 | 0 | 0 | |
Cash Fr. Inv. | -15 | 1 | -5 | -6 | 3 | 2 | 0 | 0 | |||
Cash Fr. Finan. | 2 | 1 | 1 | -2 | 0 | ||||||
Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
Cash & Cash Eqvt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Tue, 16 May 2023
Compliances-Reg.24(A)-Annual Secretarial Compliance Annual Secretarial Compliance. |
Fri, 12 May 2023
Board Meeting Intimation for Intimation Of The Board Meeting Of The Company. TRANSGENE BIOTEK LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2023 inter alia to consider and approve This is to inform you that a meeting of Board of Directors of the Company will be held on Tuesday 30th May 2023.1) To consider and approve the Audited Financial Results of the Company for the Quarter and Financial Year ended 31 st March 2023.2) Any other Business matter with the permission of the Chair. |
Fri, 12 May 2023
Intimation Of Non-Applicability Of Regulation 32(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Quarter And Year Ended On 31St March 2023. Hence the Statement of Deviation or Variation in Public Issue Rights Issue Preferential Issue etc. under Regulation 32(1) of SEBI (Listing Obligations Disclosure Requirements) Regulations 2015 for the quarter and financial year ended 31st March 2023 is not applicable to the Company. |
Fri, 26 May 2023 |
|
|
|
|
|